Drugs / IPV
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT03890497 Comparator | Sep 2018 → Sep 2022 | poliomyelitis | International Centre for Diarrhoeal Disease Research, Bangladesh | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03890497 ↗ |
| Modality | Vaccine | “inactivated poliovirus vaccine (IPV)” NCT03890497 ↗ |
| Route | Intramuscular | “IPV (.5mL) can be administered subcutaneously (SC) or IM” NCT03890497 ↗ |
| Route | Subcutaneous | “IPV (.5mL) can be administered subcutaneously (SC) or IM” NCT03890497 ↗ |